An exploration of the experiences of professionals supporting patients approaching the end of life in medicines management at home. A qualitative study

BMC Palliative Care - 2020
Eleanor Wilson1, Glenys Caswell1, Asam Latif1, Claire Anderson2, Christina Faull3, Kristian Pollock1
1School of Health Sciences, University of Nottingham, Nottingham, UK
2School of Pharmacy, University of Nottingham, Nottingham, UK
3LOROS Hospice, Leicester, UK

Tóm tắt

Abstract Background The management of medicines towards the end of life can place increasing burdens and responsibilities on patients and families. This has received little attention yet it can be a source of great difficulty and distress patients and families. Dose administration aids can be useful for some patients but there is no evidence for their wide spread use or the implications for their use as patients become increasing unwell. The study aimed to explore how healthcare professionals describe the support they provide for patients to manage medications at home at end of life. Methods Qualitative interview study with thematic analysis. Participants were a purposive sample of 40 community healthcare professionals (including GPs, pharmacists, and specialist palliative care and community nurses) from across two English counties. Results Healthcare professionals reported a variety of ways in which they tried to support patients to take medications as prescribed. While the paper presents some solutions and strategies reported by professional respondents it was clear from both professional and patient/family caregiver accounts in the wider study that rather few professionals provided this kind of support. Standard solutions offered included: rationalising the number of medications; providing different formulations; explaining what medications were for and how best to take them. Dose administration aids were also regularly provided, and while useful for some, they posed a number of practical difficulties for palliative care. More challenging circumstances such as substance misuse and memory loss required more innovative strategies such as supporting ways to record medication taking; balancing restricted access to controlled drugs and appropriate pain management and supporting patient choice in medication use. Conclusions The burdens and responsibilities of managing medicines at home for patients approaching the end of life has not been widely recognised or understood. This paper considers some of the strategies reported by professionals in the study, and points to the great potential for a more widely proactive stance in supporting patients and family carers to understand and take their medicines effectively. By adopting tailored, and sometimes, ‘outside the box’ thinking professionals can identify immediate, simple solutions to the problems patients and families experience with managing medicines.

Từ khóa


Tài liệu tham khảo

Maidment ID, Aston L, Moutela T, Fox CG, Hilton A. A qualitative study exploring medication management in people with dementia living in the community and the potential role of the community pharmacist. Health Expect. 2017. https://doi.org/10.1111/hex.12534.

Notenboom K, Beers E, van Riet-Nales D, et al. Practical Problems with Medication Use that Older People Experience: A Qualitative Study. J Am Geriatr Soc. 2014;62:2339–44.

Raynor D, Blenkinsopp A, Knapp P, et al. A systematic review of quantitative and qualitative research on the role and effectiveness of written information available to patients about individual medicines. Health Technol Assess. 2007;11:1–178.

Nunes V, Neilson J, O’Flynn N, et al. Clinical Guidelines and Evidence Review for Medicines Adherence: involving patients in decisions about prescribed medicines and supporting adherence. NICE Clinical Guidline, London: National Collaborating Centre for Primary Care and Royal College of General Practitioners, 2009. https://www.nice.org.uk/guidance/cg76/evidence/full-guideline-pdf-242062957.

Alsaeed D, Jamieson E, Gul MO, Smith FJ. Challenges to optimal medicines use in people living with dementia and their caregivers: A literature review. Int J Pharm. 2016;512:396–404.

Archer W, Latif A, Faull C. Communicating with palliative care patients nearing the end of life, their families and carers. Pharm J. 2017;298.

Elliott RA. Appropriate use of dose administration aids. Aust Prescr. 2014;37:46–50.

Lecouturier J, Cunningham B, Campbell D, Copeland R. Medication compliance aids: a qualitative study of users' views. Br J Gen Pract. 2011;61:93–100.

Royal Pharmaceutical Society. Improving patient outcomes: The better use of multi-compartment compliance aids. https://www.rpharms.com/Portals/0/RPS%20document%20library/Open%20access/Support/toolkit/rps-mca-july-2013.pdf2013.

Robinson J. Are we dispensing too many multicompartment compliance aids? Pharm J. 2019; 8th Feb 2019. . https://www.pharmaceutical-journal.com/news-and-analysis/features/are-we-dispensing-too-many-multicompartment-compliance-aids/20206131.article.

Orlu-Gul M, Raimi-Abraham B, Jamieson E, et al. Public engagement workshop: How to improve medicines for older people? Int J Pharm. 2014;459:65–9.

While C, Duane F, Beanland C, Koch S. Medication management: The perspectives of people with dementia and family carers. Dementia. 2012. https://doi.org/10.1177/1471301212444056.

Duerden M, Avery T, Payne R. Polypharmacy and medicines optimisation: Making it safe and sound. London: King's Fund; 2013. https://www.kingsfund.org.uk/sites/default/files/field/field_publication_file/polypharmacy-and-medicines-optimisation-kingsfund-nov13.pdf.

Pype P, Mertens F, Helewaut F, D'Hulster B, De Sutter A. Potentially inappropriate medication in primary care at the end of life: a mixed-method study. Acta Clin Belg. 2018;73:213–9.

Lindsay J, Dooley M, Martin J, Fay M, Kearney A, Barras M. Reducing potentially inappropriate medications in palliative cancer patients: evidence to support deprescribing approaches. Support Care Cancer. 2014;22:1113–9.

McNeil MJ, Kamal AH, Kutner JS, Ritchie CS, Abernethy AP. The Burden of Polypharmacy in Patients Near the End of Life. J Pain Symptom Manag. 2016;51:178–83.e2.

Royal Pharmaceutical Society. Polypharmacy: Getting our medicines right. https://www.rpharms.com/recognition/setting-professional-standards/polypharmacy-getting-our-medicines-right2019.

PrescQIPP. Polypharmacy and deprescribing. https://www.prescqipp.info/our-resources/webkits/polypharmacy-and-deprescribing/2019.

Wilson E, Caswell G, Turner N, Pollock K. Managing Medicines for Patients Dying at Home: A Review of Family Caregivers' Experiences. J Pain Symptom Manag. 2018. https://doi.org/10.1016/j.jpainsymman.2018.08.019.

Currow DC, Stevenson JP, Abernethy AP, Plummer J, Shelby-James TM. Prescribing in Palliative Care as Death Approaches. J Am Geriatr Soc. 2007;55:590–5.

Sheehy-Skeffington B, McLean S, Bramwell M, O'Leary N, O'Gorman A. Caregivers Experiences of Managing Medications for Palliative Care Patients at the End of Life: A Qualitative Study. Am J Hosp Palliat Med. 2014;31:148–54.

Morin L, Vetrano DL, Rizzuto D, Calderón-Larrañaga A, Fastbom J, Johnell K. Choosing Wisely? Measuring the Burden of Medications in Older Adults near the End of Life: Nationwide, Longitudinal Cohort Study. Am J Med. 2017;130:927–36.e9.

May CR, Eton DT, Boehmer K, et al. Rethinking the patient: using Burden of Treatment Theory to understand the changing dynamics of illness. BMC Health Serv Res. 2014;14:281.

Alhusein N, Macaden L, Smith A, et al. 'Has she seen me?': a multiple methods study of the pharmaceutical care needs of older people with sensory impairment in Scotland. BMJ Open. 2018;8:e023198.

Hughes CM. Medication Non-Adherence in the Elderly: How Big is the Problem? Drugs Aging. 2004;21:793–811.

Gellad WF, Grenard JL, Marcum ZA. A Systematic Review of Barriers to Medication Adherence in the Elderly: Looking Beyond Cost and Regimen Complexity. Am J Geriatr Pharmacother. 2011;9:11–23.

Shin J, Habermann B, Pretzer-Aboff I. Challenges and strategies of medication adherence in Parkinson's disease: A qualitative study. Geriatr Nurs. 2015;36:192–6.

Chapman S. Looking at medication adherence: An evidence review. Br J Commun Nurs. 2017;22:485–7.

Pound P, Britten N, Morgan M, et al. Resisting medicines: a synthesis of qualitative studies of medicine taking. Soc Sci Med. 2005;61:133–55.

Fallsberg M. Reflections on medicines and medication: A qualitative analysis among people on long term drug regiments. Sweden: Linkoping University: Swedish Pharmaceutical Press; 1991.

Payne S, Turner M, Seamark D, et al. Managing end of life medications at home—accounts of bereaved family carers: a qualitative interview study. BMJ Support Palliat Care. 2015;5:181–8.

Anderson BA, Kralik D. Palliative care at home: Carers and medication management. Palliat Support Care. 2008;6:349–56.

Israel F, Reymond L, Slade G, Menadue S, Charles MA. Lay caregivers' perspectives on injecting subcutaneous medications at home. Int J Palliat Nurs. 2008;14:390–5.

Rosenberg JP, Bullen T, Maher K. Supporting Family Caregivers With Palliative Symptom Management: A Qualitative Analysis of the Provision of an Emergency Medication Kit in the Home Setting. Am J Hosp Palliat Med. 2015;32:484–9.

Lau DT, Berman R, Halpern L, Pickard AS, Schrauf R, Witt W. Exploring Factors that Influence Informal Caregiving in Medication Management for Home Hospice Patients. J Palliat Med. 2010;13:1085–9.

Kelley M, Demiris G, Nguyen H, Oliver DP, Wittenberg-Lyles E. Informal hospice caregiver pain management concerns: A qualitative study. Palliat Med. 2013;27:673–82.

Poolman M, Roberts J, Byrne A, et al. CARer-ADministration of as-needed subcutaneous medication for breakthrough symptoms in homebased dying patients (CARiAD): study protocol for a UK-based open randomised pilot trial. Trials. 2019;20:105.

Lee L, Howard K, Wilkinson L, Kern C, Hall S. Developing a policy to empower informal carers to administer subcutaneous medication in community palliative care; a feasibility project. Int J Palliat Nurs. 2016;22:369–78.

National Institute for Health and Care Excellence. Multimorbidity and polypharmacy. In: NICE, (ed.). NICE Guidance. https://www.nice.org.uk/advice/ktt18/chapter/evidence-context2017.

Maidment I, Booth A, Mullan J, McKeown J, Bailey S, Wong G. Developing a framework for a novel multi-disciplinary, multi-agency intervention(s), to improve medication management in community-dwelling older people on complex medication regimens (MEMORABLE)––a realist synthesis. Syst Rev. 2017;6:125.

National Institute for Health and Care Excellence. Caring for the Dying Adult: NICE guideline. London: NICE; 2015. http://www.nice.org.uk/guidance/ng31/resources/care-of-dying-adults-in-the-last-days-of-life-1837387324357.

Department of Health. End of Life Care Strategy - Promoting high quality care for all adults at end of life. London: Department of Health; 2008. http://www.cpa.org.uk/cpa/End_of_Life_Care_Strategy.pdf.

Gomes B, Calanzani N, Higginson I. Local preferences and place of death in regions within England 2010: Cicely Saunders Institute; 2011. http://www.endoflifecare-intelligence.org.uk/resources/publications/lp_and_place_of_death.

Brown MT, Bussell JK. Medication Adherence: WHO Cares? Mayo Clin Proc. 2011;86:304–14.

Duerden M. What is the place for monitored dosage systems? Drug Ther Bull. 2018;56:102–6.

Nunney J, Raynor D. How are multi-compartment compliance aids used in primary care? Pham J. 2001;267:784–9.

Gardiner C, Gott M, Ingleton C, Hughes P, Winslow M, Bennett MI. Attitudes of Health Care Professionals to Opioid Prescribing in End-of-Life Care: A Qualitative Focus Group Study. J Pain Symptom Manag. 2012;44:206–14.

Office of National Statistics. Statistical bulletin: National Survey of Bereaved People (VOICES): England, 2015: Quality of care delivered in the last 3 months of life for adults who died in England. London: Office of National Statistics; 2015. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/healthcaresystem/bulletins/nationalsurveyofbereavedpeoplevoices/england2015.

Kuruvilla L, Weeks G, Eastman P, George J. Medication management for community palliative care patients and the role of a specialist palliative care pharmacist: A qualitative exploration of consumer and health care professional perspectives. Palliat Med. 2018;32:1369–77.

Krzyżaniak N, Pawłowska I, Bajorek B. An overview of pharmacist roles in palliative care: a worldwide comparison; 2016. p. 160–73.

O’Connor M, Fisher C, French L, Halkett G, Jiwa M, Hughes J. Exploring the community pharmacist's role in palliative care: Focusing on the person not just the prescription. Patient Educ Couns. 2011;83:458–64.

Tait PA, Gray J, Hakendorf P, Morris B, Currow DC, Rowett DS. Community pharmacists: a forgotten resource for palliative care. BMJ Support Palliat Care. 2013;3:436–43.

Savage I, Blenkinsopp A, Closs SJ, Bennett MI. ‘Like doing a jigsaw with half the parts missing’: community pharmacists and the management of cancer pain in the community. Int J Pharm Pract. 2013;21:151–60.

Latif A. Community pharmacy Medicines Use Review: current challenges. Integr Pharm Res Pract. 2018;7:83–92.

Thông tin
Thông tin xuất bản

BMC Palliative Care

Thông tin tác giả